Kelvin lead £1.1m investment in ProFactor Pharma after breakthrough in bid to end haemophilia drug shortage
Edinburgh life sciences firm ProFactor Pharma (PFP) has secured the £1.1 million second part of a funding round after its research into haemophilia treatment surpassed expectations. Investment [...]
